Hiba Dagher, MD

Postdoctoral Fellow
UT MD Anderson Cancer Center

Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Hiba Dagher, MD, is a postdoctoral research fellow at MD Anderson Cancer Center and is involved in clinical research related to invasive fungal infections, bloodstream and line infections, antimicrobial therapies and COVID-19 infections in immunocompromised cancer patients. She received her medical degree from the American University of Beirut in 2019.

Poster(s):

1182 - The Real-World Use of Isavuconazole as Primary or salvage Therapy of Invasive Fungal infections in High-Risk Patients with Hematologic Malignancy or Stem Cell Transplant
1228 - The Role of Procalcitonin (PCT) and Lactic Acid in Febrile Neutropenic Cancer Patients in an Oncological Emergency Center
1636 - Risk of Latent Tuberculosis Reactivation in Patients Treated with Checkpoint Inhibitors Immunotherapy Compared to Other Anti-Cancer Therapies including Hematopoietic Cell Transplantation